EP Patent

EP3473246A1 — Immediate release abuse deterrent formulations

Assigned to Capsugel Belgium NV · Expires 2019-04-24 · 7y expired

What this patent protects

The present invention provides immediate release abuse resistant or deterrent formulations such as ingestible dosage form articles suitable for the delivery of one or more medicaments or other active materials.

USPTO Abstract

The present invention provides immediate release abuse resistant or deterrent formulations such as ingestible dosage form articles suitable for the delivery of one or more medicaments or other active materials.

Drugs covered by this patent

Patent Metadata

Patent number
EP3473246A1
Jurisdiction
EP
Classification
Expires
2019-04-24
Drug substance claim
No
Drug product claim
No
Assignee
Capsugel Belgium NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.